TY  - EJOU
AU  - HUANG, BAOXING 
AU  - JIA, ZICHANG 
AU  - FU, CHENCHEN 
AU  - CHEN, MOXIAN 
AU  - SU, ZEZHUO 
AU  - CHEN, YUNSHENG 

TI  - Oncogenic and tumor-suppressive roles of Lipocalin 2 (LCN2) in tumor progression
T2  - Oncology Research

PY  - 2025
VL  - 33
IS  - 3
SN  - 1555-3906

AB  - Lipocalin-2 (LCN2) is a member of the lipocalin superfamily with multiple functions and can participate in the transport of a variety of small lipophilic ligands <i>in vivo</i>. LCN2 is significantly expressed in various tumors and plays an important role in regulating tumor cell proliferation, invasion, and metastasis. The specific actions of LCN2 in tumors may vary depending on the particular type of cancer involved. In this review, we provide an extensive overview of the transcriptional and post-transcriptional regulation of LCN2 in health and disease. Furthermore, we summarize the impact of LCN2 dysregulation in a broad range of tumors. Lastly, we examine the mechanisms of action of LCN2 during tumorigenesis, progression, and metastasis. Understanding the complex relationships between LCN2 and tumor development, progression, and metastasis is vital for advancing our knowledge of cancer biology, developing biomarkers for diagnosis and clinical decision-making, and creating therapeutic strategies to improve the management of patients with cancer.
KW  - Tumor progression; Gene regulation; Oncogenesis; Lipocalin 2 (LCN2)

DO  - 10.32604/or.2024.051672